Zwitterionic nanoparticles for thermally activated drug delivery in hyperthermia cancer treatment
Camillo Colli,Ilenia Masi,Emanuela Jacchetti,Silvia Santoni,Mattia Sponchioni,Bianca Maria Colosimo,Laura Rosanò,Manuela Teresa,Emanuele Mauri,Davide Moscatelli
DOI: https://doi.org/10.1039/d4nr00723a
IF: 6.7
2024-06-08
Nanoscale
Abstract:Hyperthermia is considered a promising strategy to boost the curative outcome of traditional chemotherapeutic treatments. However, this thermally mediated drug delivery is still affected by important limitations. First, the poor accumulation of the conventional anticancer formulations in the target site limits the bioavailability of the active principle and induces off-site effects. In addition, some tumoral scenarios, such as ovarian carcinoma, are characterized by cell thermotolerance, which induces tumoral cells to activate self-protecting mechanisms against high temperatures. To overcome these constraints, we developed thermoresponsive nanoparticles (NPs) with an upper critical solution temperature (UCST) to intracellularly deliver a therapeutic payload and release it on-demand, through hyperthermia stimulation. These NPs were synthetized via reversible addition–fragmentation chain transfer (RAFT) emulsion polymerization, and combine polyzwitterionic stabilizing segments and an oligoester-based biodegradable core. By leveraging the pseudo-living nature of RAFT polymerization, important physicochemical properties of the NPs were controlled and optimized, including their cloud point (Tcp) and size. We have tuned the Tcp of NPs to match the therapeutic needs of hyperthermia treatments at 43 °C and tested the nanocarriers as delivery system of paclitaxel, a common anticancer drug. The NPs released almost entirely the encapsulated drug only following 1 h incubation at 43 °C, whereas retained more than 95% of the payload in physiological environment (37 °C), thus demonstrating their efficacy as on-demand drug delivery systems. The administration of drug-loaded NPs to ovarian cancer cells led to therapeutic effects outperforming the conventional administration of non-encapsulated paclitaxel, which highlights the potential of the zwitterionic UCST-type NPs as innovative hyperthermia-responsive drug delivery system.
materials science, multidisciplinary,physics, applied,nanoscience & nanotechnology,chemistry